• 医学文献
  • 知识库
  • 评价分析
  • 全部
  • 中外期刊
  • 学位
  • 会议
  • 专利
  • 成果
  • 标准
  • 法规
  • 临床诊疗知识库
  • 中医药知识库
  • 机构
  • 作者
热搜词:
换一批
论文 期刊
取消
高级检索

检索历史 清除

医学文献>>
  • 全部
  • 中外期刊
  • 学位
  • 会议
  • 专利
  • 成果
  • 标准
  • 法规
知识库 >>
  • 临床诊疗知识库
  • 中医药知识库
评价分析 >>
  • 机构
  • 作者
热搜词:
换一批

A practical "preTACs-cytoblot" platform accelerates the streamlined development of PROTAC-based protein degraders.

广告
第一作者: Zijian,Rao
第一单位: Institute of Pharmacology & Toxicology, Zhejiang Province Key Laboratory of Anti-Cancer Drug Research, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, PR China.
作者: Zijian,Rao [1] ; Kailin,Li [1] ; Ju,Hong [1] ; Danni,Chen [1] ; Baoli,Ding [1] ; Li,Jiang [1] ; Xuxin,Qi [1] ; Jiawen,Hu [1] ; Bo,Yang [2] ; Qiaojun,He [3] ; Xiaowu,Dong [4] ; Ji,Cao [5] ; Cheng-Liang,Zhu [6]
作者单位: Institute of Pharmacology & Toxicology, Zhejiang Province Key Laboratory of Anti-Cancer Drug Research, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, PR China. [1] Institute of Pharmacology & Toxicology, Zhejiang Province Key Laboratory of Anti-Cancer Drug Research, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, PR China; Innovation Institute for Artificial Intelligence in Medicine, Zhejiang University, Hangzhou, 310016, PR China; Hangzhou Institute of Innovative Medicine, Zhejiang University, Hangzhou, 310058, PR China. [2] Institute of Pharmacology & Toxicology, Zhejiang Province Key Laboratory of Anti-Cancer Drug Research, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, PR China; Centre for Drug Safety Evaluation and Research of ZJU, Hangzhou, 310058, PR China; Innovation Institute for Artificial Intelligence in Medicine, Zhejiang University, Hangzhou, 310016, PR China; Hangzhou Institute of Innovative Medicine, Zhejiang University, Hangzhou, 310058, PR China; Cancer Centre, Zhejiang University, Hangzhou, 310058, PR China. [3] Institute of Pharmacology & Toxicology, Zhejiang Province Key Laboratory of Anti-Cancer Drug Research, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, PR China; Innovation Institute for Artificial Intelligence in Medicine, Zhejiang University, Hangzhou, 310016, PR China; Hangzhou Institute of Innovative Medicine, Zhejiang University, Hangzhou, 310058, PR China; Cancer Centre, Zhejiang University, Hangzhou, 310058, PR China. [4] Institute of Pharmacology & Toxicology, Zhejiang Province Key Laboratory of Anti-Cancer Drug Research, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, PR China; Innovation Institute for Artificial Intelligence in Medicine, Zhejiang University, Hangzhou, 310016, PR China; Hangzhou Institute of Innovative Medicine, Zhejiang University, Hangzhou, 310058, PR China; Cancer Centre, Zhejiang University, Hangzhou, 310058, PR China; Engineering Research Center of Innovative Anticancer Drugs, Ministry of Education, China. Electronic address: caoji88@zju.edu.cn. [5] Institute of Pharmacology & Toxicology, Zhejiang Province Key Laboratory of Anti-Cancer Drug Research, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, PR China; Centre for Drug Safety Evaluation and Research of ZJU, Hangzhou, 310058, PR China; Innovation Institute for Artificial Intelligence in Medicine, Zhejiang University, Hangzhou, 310016, PR China; Hangzhou Institute of Innovative Medicine, Zhejiang University, Hangzhou, 310058, PR China; Engineering Research Center of Innovative Anticancer Drugs, Ministry of Education, China. Electronic address: chengliangzhu@zju.edu.cn. [6]
DOI 10.1016/j.ejmech.2023.115248
PMID 36905918
发布时间 2023-04-04
提交
  • 浏览0

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!

特别提示:本网站仅提供医学学术资源服务,不销售任何药品和器械,有关药品和器械的销售信息,请查阅其他网站。

  • 客服热线:4000-115-888 转3 (周一至周五:8:00至17:00)

  • |
  • 客服邮箱:yiyao@wanfangdata.com.cn

  • 违法和不良信息举报电话:4000-115-888,举报邮箱:problem@wanfangdata.com.cn,举报专区

官方微信
万方医学小程序
new翻译 充值 订阅 收藏 移动端

官方微信

万方医学小程序

使用
帮助
Alternate Text
调查问卷